Tarceva
Generic Name: erlotinib
Brand Names: Tarceva What is erlotinib?Erlotinib is a cancer chemotherapy medication. Erlotinib interferes with the growth of cancer cells and slows their growth and spread in the body. Erlotinib is used in the treatment of non-small cell lung cancer. Erlotinib may also be used for purposes other than those listed in this medication guide. What is the most important information I should know about erlotinib?If you experience any of the following serious side effects from erlotinib, contact your doctor immediately: an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); lung problems (especially new or worsening difficulty breathing, shortness of breath, increased coughing, fever, or chest pain); severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or eye pain or irritation.
What should I discuss with my healthcare provider before taking erlotinib?Do not use erlotinib without first talking to your doctor if you have You may not be able to take erlotinib, or you may require a dosage adjustment or special monitoring if you have any of the conditions listed above. Erlotinib is in the FDA pregnancy category D. This means that it is known to be harmful to an unborn baby. Do not use erlotinib without first talking to your doctor if you are pregnant or could become pregnant during treatment. Birth control should be used during treatment with erlotinib and for at least 2 weeks after treatment completion. It is not known whether erlotinib passes into breast milk. Do not take erlotinib without first talking to your doctor if you are breast-feeding a baby.
|
